Published in Dig Dis Sci on October 01, 2000
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Molecular cloning and expression of human hepatocyte growth factor. Nature (1989) 6.91
Acute liver failure: redefining the syndromes. Lancet (1993) 4.99
Structure of a human histone cDNA: evidence that basally expressed histone genes have intervening sequences and encode polyadenylylated mRNAs. Proc Natl Acad Sci U S A (1985) 3.51
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun (1989) 3.21
Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res (1987) 2.65
Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci U S A (1988) 2.62
Analysis of histone gene expression during the cell cycle in HeLa cells by using cloned human histone genes. Proc Natl Acad Sci U S A (1982) 2.28
Organization of human histone genes. Proc Natl Acad Sci U S A (1982) 2.10
Cell-cycle regulation of histone gene expression. Cell (1986) 2.09
Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology (1991) 1.88
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci U S A (1992) 1.70
Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J Clin Invest (1991) 1.70
Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Hepatology (1989) 1.60
Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet (1994) 1.55
Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology (1992) 1.55
Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun (1989) 1.51
Cell-specific expression of hepatocyte growth factor in liver. Upregulation in sinusoidal endothelial cells after carbon tetrachloride. J Clin Invest (1993) 1.44
Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (1991) 1.44
In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology (1994) 1.38
Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem Biophys Res Commun (1991) 1.33
Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun (1992) 1.20
Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J Pathol (1998) 1.15
An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur J Biochem (1991) 1.15
Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology (1992) 1.08
Hepatotropin mRNA expression in human foetal liver development and in liver regeneration. FEBS Lett (1990) 1.07
Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci U S A (1992) 1.04
Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology (1993) 1.02
Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis. Cell Growth Differ (1998) 0.98
Characterization of the scatter factor/hepatocyte growth factor gene promoter. Positive and negative regulatory elements direct gene expression to mesenchymal cells. J Biol Chem (1995) 0.96
Structural organization and the transcription initiation site of the human hepatocyte growth factor gene. Biochemistry (1991) 0.96
Organization of the human hepatocyte growth factor-encoding gene. Gene (1991) 0.95
Regulation of HGF and HGFR gene expression. EXS (1995) 0.95
Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury. Eur J Biochem (1990) 0.94
Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Liver (1999) 0.93
Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol (1992) 0.92
Hepatocyte growth factor, blood clearance, organ uptake, and biliary excretion in normal and partially hepatectomized rats. Lab Invest (1993) 0.92
Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology (1992) 0.89
Molecular cloning and characterization of cDNA encoding mouse hepatocyte growth factor. Biochim Biophys Acta (1993) 0.87
Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology (1994) 0.87
Hepatocyte growth factor supply accelerates compensatory hypertrophy caused by portal branch ligation in normal and jaundiced rats. J Surg Res (1999) 0.86
Characterization of the promoter region of the rat hepatocyte-growth-factor/scatter-factor gene. Eur J Biochem (1993) 0.85
Characterization of the 5'-flanking region of the hepatocyte growth factor gene. Biochem Biophys Res Commun (1993) 0.85
Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology (1996) 0.84
Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure. J Hepatol (1997) 0.84
Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res (1998) 0.81
Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation. Surgery (1996) 0.81
Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats. Hepatology (1993) 0.80
Lack of hepatocyte growth factor receptor (c-met) gene expression in fulminant hepatic failure livers before transplantation. Dig Dis Sci (1997) 0.78
Efficient extraction by the liver governs overall elimination of hepatocyte growth factor in rats. J Pharmacol Exp Ther (1999) 0.77
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell (2000) 5.31
Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94
An iron-regulated ferric reductase associated with the absorption of dietary iron. Science (2001) 2.90
Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med (1976) 1.98
Adaptive responses of rat tissue isoferritins to iron administration. Changes in subunit synthesis, isoferritin abundance, and capacity for iron storage. J Biol Chem (1981) 1.58
Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. Characterization by high performance liquid chromatography and nuclear magnetic resonance spectroscopy. J Biol Chem (1989) 1.54
Determinants of the interaction between the iron-responsive element-binding protein and its binding site in rat L-ferritin mRNA. J Biol Chem (1990) 1.42
New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum Mol Genet (1995) 1.38
Over-expression of GATA-6 in Xenopus embryos blocks differentiation of heart precursors. EMBO J (1997) 1.37
The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes. Biochem J (1984) 1.26
The human and mouse GATA-6 genes utilize two promoters and two initiation codons. J Biol Chem (1999) 1.17
Histocompatibility antigens as markers of abnormal iron metabolism in patients with idiopathic haemochromatosis and their relatives. Lancet (1977) 1.09
Treatment of rheumatoid arthritis with desferrioxamine. Q J Med (1986) 1.07
Uptake and release of transferrin and iron by mitogen-stimulated human lymphocytes. Br J Haematol (1983) 1.06
Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas. World J Gastroenterol (1998) 1.02
Chelation of transferrin iron by desferrioxamine in K562 cells. The partition of iron between ferrioxamine and ferritin. Biochem J (1988) 1.00
Hip arthropathy in genetic hemochromatosis. Radiographic and histologic features. Arthritis Rheum (1991) 0.98
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology (1990) 0.98
Proceedings: Hepatoma in chronic liver disease. Gut (1976) 0.97
The iron content of human liver and spleen isoferritins correlates with their isoelectric point and subunit composition. Biochem Biophys Res Commun (1978) 0.97
Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol (1997) 0.96
Intracellular processing of transferrin and iron by isolated rat hepatocytes. Biochem J (1985) 0.96
Variation in the distribution of two human heart ferritin species. Isoferritin profile and subunit composition in normal and iron-overloaded subjects. Biochem J (1977) 0.95
Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs. FEBS Lett (1988) 0.94
Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem (1988) 0.93
A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis. Gut (1996) 0.89
Release of iron from the two iron-binding sites of transferrin by cultured human cells: modulation by methylamine. Biochemistry (1985) 0.89
Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis. Clin Endocrinol (Oxf) (1993) 0.89
Intracellular forms of iron during transferrin iron uptake by mitogen-stimulated human lymphocytes. Br J Haematol (1986) 0.88
Regulation of the hepatic transferrin receptor in hereditary hemochromatosis. Hepatology (1989) 0.88
Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-beta1. Biochem Biophys Res Commun (2000) 0.88
Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects. Br Med J (Clin Res Ed) (1985) 0.88
Molecular cloning of human GATA-6 DNA binding protein: high levels of expression in heart and gut. Biochim Biophys Acta (1997) 0.88
Nontransferrin-bound iron in plasma from hemochromatosis patients: effect of phlebotomy therapy. Blood (1988) 0.87
The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells. Biochem J (1986) 0.87
Abnormal in vitro function of a variant human transferrin. Br J Haematol (1984) 0.84
Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results. The European Haemochromatosis Consortium. Nat Genet (1999) 0.83
Down-regulation of liver iron-regulatory protein 1 in haemochromatosis. Biochem Soc Trans (2002) 0.83
Transferrin and cellular iron exchange. Clin Sci (Lond) (1984) 0.83
Antibodies to atypical mycobacteria in primary biliary cirrhosis. J Hepatol (1994) 0.82
Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Ferroxidase activity and phenanthroline-detectable copper in human serum in Wilson's disease. Free Radic Res Commun (1989) 0.81
Dual pathways for the uptake of rat asialotransferrin by rat hepatocytes. J Biol Chem (1983) 0.81
Hepatocellular carcinoma arising in the absence of cirrhosis in genetic haemochromatosis: three case reports and review of literature. Eur J Gastroenterol Hepatol (1999) 0.80
Effect of excess dietary zinc on tissue storage of iron in rats. J Nutr (1981) 0.80
Rapid one-step purification of ferritin from cell-free translation systems. Anal Biochem (1982) 0.80
Heterogeneous distribution of transferrin receptors on parenchymal and nonparenchymal liver cells: biochemical and morphological evidence. Blood (1987) 0.79
The iron-chelating potential of silybin in patients with hereditary haemochromatosis. Eur J Clin Nutr (2010) 0.79
Hypogonadism and sexual dysfunction in hemochromatosis: the effects of cirrhosis and diabetes. J Clin Endocrinol Metab (1989) 0.78
Inheritance of idiopathic haemochromatosis. Lancet (1977) 0.78
Molecular analysis of the human MHC class I region in hereditary haemochromatosis. A study by pulsed-field gel electrophoresis. Hum Genet (1990) 0.77
Occupancy of the iron-binding sites of human transferrin in sera obtained from different anatomical sites. Klin Wochenschr (1989) 0.77
Sodium handling in the isolated perfused kidney of the cirrhotic rat. Clin Sci (Lond) (1989) 0.77
Relationship between duodenal cytosolic aconitase activity and iron status in the mouse. Biochim Biophys Acta (1995) 0.76
Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis. Biochim Biophys Acta (1989) 0.76
Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney. Adv Prostaglandin Thromboxane Leukot Res (1991) 0.76
Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney. Kidney Int (1992) 0.76
Impaired natriuretic response to atrial natriuretic peptide in the isolated kidney of rats with experimental cirrhosis. Clin Sci (Lond) (1990) 0.76
Hemochromatosis-related mutation detection. Blood (1998) 0.76
Iterative endocytosis of transferrin by K562 cells. Biochem J (1994) 0.76
Familial iron storage disease in two sisters. Proc R Soc Med (1976) 0.75
Serum-ferritin in diagnosis of haemochromatosis. Lancet (1977) 0.75
Wash off liver cytology: a complementary diagnostic tool to liver biopsy. J Clin Pathol (1986) 0.75
Haemochromatosis. J R Soc Med (1979) 0.75
A biochemical comparison of normal human liver and hepatocellular carcinoma ferritins. Biochem J (1980) 0.75
Genetic iron overload. J R Soc Med (1989) 0.75
Haemochromatosis: a gene at last? J Med Genet (1997) 0.75
Phytohaemagglutinin induced proliferation of lymphocytes from patients with rheumatoid arthritis and iron deficiency. Ann Rheum Dis (1988) 0.75
Metal ions catalytic for free radical reactions in the plasma of patients with fulminant hepatic failure. Free Radic Res (1994) 0.75
Plasma immunoreactive beta-melanocyte-stimulating hormone in chronic liver disease and fulminant hepatic failure. J Invest Dermatol (1978) 0.75
Hepatic transferrin receptors in hereditary hemochromatosis. Hepatology (1988) 0.75
Measurement of ferritin in serum by an indirect competitive enzyme-linked immunosorbant assay. Clin Chem (1988) 0.75
Optimizing the immunohistochemical signal from the transferrin receptor in liver tissue. Histochem J (1989) 0.75
Conformational analysis of pentapeptide sequences matching a proposed recognition motif for lysosomal degradation. Biochim Biophys Acta (1996) 0.75